Preclinical Capital Exhaustion

“Your early-stage funding ran out before you could afford to run clinical trials.”

Structural failure pattern in healthcare B2B

19 companies failed due to preclinical capital exhaustion in the Stressline corpus.

Deaths

Funding Raised by Companies That Failed

$6.7M

Sub-Vertical Breakdown

Other Healthcare B2B15 (79%)

Pharmacy Technology & Delivery2 (11%)

Compliance & Regulatory2 (11%)

19 companies, 59 failure dimensions coded, 2022–2022.

Related failure patterns

Outspent by bigger competitors Product claims exceeded actual capabilities Couldn't get paid by insurance

19 companies hit preclinical capital exhaustion. Will yours?

Stress-test your thesis →

Get Alerts for This Pattern

New data gets coded regularly. Get notified when this failure pattern updates.

Related methodology

All failure patterns →How the corpus is built →How scoring works →

Data sourced from SBIR/STTR databases, SEC EDGAR filings, ClinicalTrials.gov, CMS data, and founder postmortems. Coded using the Gioia qualitative methodology. Read the methodology.